Li, Xiaoyun
Wenes, Mathias
Romero, Pedro
Huang, Stanley Ching-Cheng http://orcid.org/0000-0002-6557-3737
Fendt, Sarah-Maria
Ho, Ping-Chih http://orcid.org/0000-0003-3078-3774
Article History
First Online: 26 March 2019
Competing interests
: P.R. is a member of the scientific advisory board of Immatics and NexImmune and has received speaker honoraria from AstraZeneca, Bristol-Myers Squibb and Roche and research funding from Roche in the form of a Pharma Research and Early Development (pRED) grant. S.-M.F. has received funding from Bayer and Merck. P.-C.H. has received research funding from Idorsia, Novartis and Roche (pRED grant) and speaker honoraria from Chugai and Pfizer and is a member of the scientific advisory board of Elixiron Immunotherapeutics. The other authors declare no competing interests.